Citation

Daniel J. Skiest, M.D., F.A.C.P., Zhaohui Su, Ph.D., Diane V. Havlir, M.D., Kevin R. Robertson, Ph.D., Robert W. Coombs, M.D., Ph.D., Pat Cain, R.N., Tianna Petersen, M.S., Amy Krambrink, M.S., Nasreen Jahed, M.P.H., Deborah McMahon, M.D., David M. Margolis, M.D. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS clinical trials group 5170. Journal of Infectious Diseases. 2007 May 15; 195(10):1426-36.

Citation

Kathleen Mulligan, Ph.D., Yang Yang, Ph.D., David A. Wininger, M.D., Susan L. Koletar, M.D., Robert A. Parker, Sc.D., Beverly L. Alston-Smith, M.D., Jeffrey T. Schouten, M.D.,J.D., Roger A. Fielding, Ph.D., Michael T. Basar, B.S., Steven K. Grinspoon, M.D. Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio. AIDS. 2007 Jan 02; 21(1):47-57.

Citation

J. Allen McCutchan, M.D., M.Sc., Julia (Wei) Wu, M.S., Kevin R. Robertson, Ph.D., Susan L. Koletar, M.D., Ronald J. Ellis, M.D.,Ph.D., Susan Ellen Cohn, M.D., M.P.H., Michael Taylor, Steven Woods, Robert K. Heaton, Ph.D., Judith Silverstein Currier, M.D., M.Sc., Paige L. Williams, Ph.D. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS. 2007 May 31; 21(9):1109-17.

Citation

William Douglas King, M.D., J.D., Donna DeFreitas, M.D., Kimberly Y. Smith, M.D., M.P.H., Janet Andersen, Sc.D., Lisa Patton, B.S., Oluwatoyin Adeyemi, M.D., Jennifer A. Mitty, M.D., M.P.H., Jan Fritsche, A.P.R.N., B.C., Carrie Jeffries, R.N., M.S., M.P.H., C.R.N.P.,, Melvin Littles, A.A., Margaret A. Fischl, M.D., Gregory Pavlov, Donna Mildvan, M.D. Attitudes and perceptions of AIDS clinical trials group site coordinators on HIV clinical trial recruitment and retention: a descriptive study. AIDS Patient Care and STDs. 2007 Aug 01; 21(8):551-63.

Citation

L. Zhou, Doug Kitch, M.S., Scott Evans, Ph.D., Peter Hauer, M.D., S. Raman, B.S., G. J. Ebenezer, M.B.B.S., Mariana Gerschenson, Ph.D., Christina M. Marra, M.D., Victor G. Valcour, M.D., Ramon Diaz-Arrastia, M.D., Ph.D., Karl Goodkin, M.D., Ph.D., Linda L. Millar, B.S., Sharon L. Shriver, R.Ph., M.S., David M. Asmuth, M.D., David B. Clifford, M.D., David M. Simpson, M.D., Justin C. McArthur, M.B.B.S., M.P.H. Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy. Neurology. 2007 Jun 12; 68(24):2113-9.

Citation

Nimalie D. Stone, Shelia B. Dunaway, M.D., Charles Flexner, M.D., Camlin Tierney, Ph.D., Gary B. Calandra, Ph.D., M.D., F.A.C.P., Stephen L. Becker, M.D., Ying-Jun Cao, Ilene P. Wiggins, R.N., Jeanne Conley, R.N., B.S.N., Ron T. MacFarland, Ph.D., Jeong-Gun Park, Ph.D., Christina M. Lalama, M.S., Sally Snyder, B.S., Beatrice A. Kallungal, B.S., Karin L. Klingman, M.D., Craig Hendrix, M.D., M.C. Multiple dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects. Antimicrobial Agents and Chemotherapy. 2007 Jul 01; 51(7):2351-8.

Citation

Margaret James Koziel, M.D., Marion G. Peters, M.D. Viral hepatitis in HIV infection. New England Journal of Medicine. 2007 Apr 05; 356(14):47-56.

Citation

Charles Flexner, M.D. HIV drug development: the next 25 years. Nature Reviews Drug Discovery. 2007 Dec 01; 6(12):959-66.

Citation

B. Healy, Victor DeGruttola, Sc.D. Hidden Markov models for settings with interval-censored transition times and uncertain time origin: application to HIV genetic analyses. Biostatistics. 2007 Apr 01; 8(2):438-52.

Citation

Roger Paredes, Vincent C. Marconi, Thomas B. Campbell, M.D., Daniel R. Kuritzkes, M.D. Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations. Journal of Virological Methods. 2007 Dec 01; 146(1-2):136-46.